Medical Device and Diagnostics
News & Jobs
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  
Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile


nContact, Inc. 

1001 Aviation Parkway
Suite 400
Morrisville  North Carolina  27560  U.S.A.
Phone: 919-466-9810 Fax: 919-466-9811


 Company News
nContact, Inc. Presents At The Piper Jaffray 26th Annual Healthcare Conference 12/9/2014 12:56:08 PM
nContact, Inc. Release: Convergent Procedure Using Cryoballoon Demonstrates Promise Of New Ablation Approach In The Treatment Of Persistent Atrial Fibrillation 9/25/2014 8:31:08 AM
nContact, Inc. Release: New Publication From The Valley Health System Highlights The Convergent Procedure As A "Go-To" Approach For Persistent Atrial Fibrillation Patients 3/13/2014 9:36:32 AM
nContact, Inc. Release: New Concept On Progression Of Atrial Fibrillation Points To Importance Of Comprehensive Posterior Left Atrial Ablation -- Highlights Role Of Convergent Procedure In The Treatment Of Atrial Fibrillation 3/4/2014 8:53:23 AM
nContact, Inc. Announces First Patient Treated In The CONVERGE IDE Clinical Trial - The First Head-To-Head Superiority Study Comparing The Multidisciplinary Convergent Procedure To Endocardial Catheter Ablation In Persistent Atrial Fibrillation Patients 1/9/2014 10:03:06 AM
nContact, Inc. Release: New Publication From East Jefferson General Hospital Highlights The Role Of The Convergent Procedure In Addressing Clinical And Economic Unmet Needs Of Persistent Atrial Fibrillation Patients 12/4/2013 9:16:21 AM
nContact, Inc. Release: New Data Presented at ISMICS on Outcomes for the Convergent Procedure in Treatment of Persistent and Longstanding Persistent Atrial Fibrillation Patient 6/27/2013 9:38:46 AM
Medical Device Startup nContact, Inc. Raises $6.7 Million, Wants Another $6 Million 3/11/2013 9:10:29 AM
GLP Preclinical Studies Demonstrate nContact, Inc. Ablation Lesions are Complete and Transmural 1/25/2013 9:05:37 AM
FDA Clears nContact, Inc.'s Cardiac Ablation Device, EPi-Sense® 1/17/2013 7:20:10 AM